Posted by Roger Bate My op-ed with Dinesh Thakur in The Hill today highlights the recent recommendation by Europe's chief drug regulator to suspend 700 generic drugs whose approvals were based on flawed – or forged – clinical studies conducted by GVK Bio, an Indian contract research organization. We urge U.S. Federal regulators to follow Europe’s lead and move to rescind market approval for these drugs while conducting their own investigation. You can read the op-ed here [...]

Just a few months after Alexion snapped up complement inhibitor biotech Achillion, Gemini Therapeutics has nabbed one of its key R&D execs as its new chief medical officer.

Guns N' Roses frontman Axl Rose criticized Steven Mnuchin and Trump's coronavirus response, which irked the Treasury secretary and started a Twitter spat.

Doctors have recently identified a condition called pediatric inflammatory multi-system syndrome among children who have tested positive for antibodies against COVID-19.

Three more inmates died of coronavirus and the number who are infected has more than doubled at the California state prison in Chino, officials said.

The U.S. death toll in the coronavirus outbreak surpasses 77,000 as states continue to ease restrictions and President Trump pushes for faster reopening.

Enough is enough, says a growing number of creatives from the fashion industry, including designer Kimora Lee Simmons, stylist Jeanne Yang and designer Prabal Gurung.

Nearly 100 children in the U.S. have been diagnosed with the newly identified syndrome associated with COVID-19.

On March 25, 2020, Hitachi Capital Corporation, Yokogawa Electric Corporation (TOKYO: 6841), and amnimo Inc., a subsidiary of Yokogawa, entered into a comprehensive partnership agreement with an aim to provide new services by adding Industrial IoT ("IIoT") to each company's technologies, know-how, and lease equipment.

Prof Andrew Cunningham from the Zoological Society of London said, “The emergence of COVID-19 was not only predictable, but it was also predicted (in the sense that) there would be another viral emergence from wildlife that would be a public health threat.”

The company issued a response following “chatter based on an Asian talk show commentary,” it said.

The post Temasek refutes claim CEO Ho Ching makes $70m a year appeared first on DealStreetAsia.

Charles Lin will take on his leading role at CLSA, the HK-based broker Citic Securities acquired in 2013.

The post China’s Citic Securities hires Vanguard ex-Asia boss for global drive appeared first on DealStreetAsia.

The move comes as the online platform’s business has shifted to focus more on peddling intellectual property.

The post China Literature replaces founding team with Tencent veterans appeared first on DealStreetAsia.

The White House named three nominees to sit on a board that oversees federal employee pension funds.

The post White House appointments to impact pension fund investment decisions in China appeared first on DealStreetAsia.

Marknum Technology has secured $14 million in its Series B round led by Aurora Private Equity and GSR Ventures. 

The post China Digest: Marknum nets over $14m; SDIC invests in HGZ appeared first on DealStreetAsia.

Our Q1 report delves into investment trends in individual sectors and at different funding stages.

The post March megadeals breathe life into Greater China’s venture scene in Q1 appeared first on DealStreetAsia.

The Series D+ round was led by state-owned China Internet Investment Fund.

The post China’s ASR Microelectronics snags $119m at over $1.6b valuation appeared first on DealStreetAsia.

Innoangel Fund now manages over 3 billion yuan ($425 million).

The post Chinese early-stage tech investor Innoangel Fund closes RMB fund at $51m appeared first on DealStreetAsia.

Chehaoduo was valued at over $9 billion after Vision Fund injected $1.5 billion into the firm in February 2019.

The post Car trader Chehaoduo nets $200m from SoftBank Vision Fund, Sequoia China appeared first on DealStreetAsia.

Returning investors Xiaomi Corporation and Gaocheng Capital also participated in the fresh round.

The post Chinese tax platform Huisuanzhang snags $60m round led by Sunshine Insurance appeared first on DealStreetAsia.

Tencent, which first invested in Enflame's pre-Series A round in July 2018, also topped up.

The post Tencent-backed Chinese AI startup Enflame raises nearly $100m Series B funding appeared first on DealStreetAsia.

The VC firm manages four funds with about 2.5 billion yuan ($352 million) in total AUM.

The post Chinese VC Linear Capital reaches first close of latest USD fund at $110m appeared first on DealStreetAsia.

The financing was led by state-owned China Life Insurance Group’s healthcare fund. 

The post Chinese biotech firm Vazyme snags $78m in Series C round appeared first on DealStreetAsia.

Illicit nuclear detonations are anything but secret